↓ Skip to main content

Human growth hormone and glutamine for patients with short bowel syndrome

Overview of attention for article published in Cochrane database of systematic reviews, June 2010
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
83 Mendeley
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human growth hormone and glutamine for patients with short bowel syndrome
Published in
Cochrane database of systematic reviews, June 2010
DOI 10.1002/14651858.cd006321.pub2
Pubmed ID
Authors

Paul W Wales, Ahmed Nasr, Nicole de Silva, Janet Yamada

Abstract

There has been clinical enthusiasm for treating short bowel patients with human recombinant growth hormone and/or glutamine in hopes of reducing parenteral nutrition dependency. It has been more than a decade since Byrne and colleagues reported enhanced absorption of nutrients, improved weight gain, and reduction in parenteral nutrition requirements with the administration of a combination of human growth hormone (HGH) and glutamine in patients with short bowel syndrome. Other studies have reported inconsistent results.

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 1%
Unknown 82 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 20%
Student > Bachelor 15 18%
Researcher 10 12%
Student > Ph. D. Student 9 11%
Student > Doctoral Student 6 7%
Other 14 17%
Unknown 12 14%
Readers by discipline Count As %
Medicine and Dentistry 39 47%
Nursing and Health Professions 10 12%
Agricultural and Biological Sciences 4 5%
Social Sciences 4 5%
Psychology 2 2%
Other 4 5%
Unknown 20 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2014.
All research outputs
#10,730,430
of 12,101,174 outputs
Outputs from Cochrane database of systematic reviews
#7,609
of 7,978 outputs
Outputs of similar age
#185,031
of 227,223 outputs
Outputs of similar age from Cochrane database of systematic reviews
#202
of 204 outputs
Altmetric has tracked 12,101,174 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 227,223 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 204 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.